mitochondria
increasingli
recogn
driver
inflammatori
respons
map
kinas
kinas
dualspecif
protein
kinas
activ
inflamm
turn
activ
map
kinas
signal
show
influenc
mitochondri
function
act
critic
mediat
inflamm
defici
mice
bone
marrow
deriv
macrophag
bmdm
secret
less
cytokin
wild
type
wt
lp
exposur
improv
mitochondri
function
measur
basal
oxygen
consumpt
rate
mitochondri
membran
potenti
atp
product
bmdm
lp
exposur
bmdm
show
signific
increas
cellular
reactiv
oxygen
speci
ro
product
well
mitochondri
superoxid
mitosox
compar
wt
activ
two
import
inflammatori
mediat
ie
nuclear
transloc
activ
key
compon
inflammasom
lower
bmdm
jnk
activ
lower
bmdm
compar
wt
exposur
lp
knockdown
sirna
wild
type
bmdm
improv
mitochondri
membran
potenti
reduc
lp
induc
activ
attenu
cytokin
secret
studi
establish
regul
mitochondri
function
inflammatori
respons
lp
suggest
may
therapeut
target
inflammatori
disord
like
sepsi
mitochondria
consid
central
hub
inflamm
new
paradigm
shift
show
mitochondria
capabl
induc
multipl
inflammatori
pathway
reflect
origin
primit
archaebacteria
mitochondri
reactiv
oxygen
speci
ro
implic
activ
major
inflammatori
transcript
factor
nfkb
nuclear
factor
kappa
b
activ
protein
addit
mitochondri
ro
membran
potenti
releas
oxid
mitochondri
dna
activ
anoth
import
inflammatori
pathway
inflammasom
mitochondri
metabol
innat
immun
intim
link
metabol
switch
oxpho
oxid
phosphoryl
glycolyt
atp
gener
like
determin
magnitud
inflammatori
respons
exampl
oxpho
defici
associ
increas
inflammatori
respons
adipocyt
macrophag
dendrit
cell
stimul
toll
like
receptor
lp
inhibit
mitochondri
activ
induc
chang
metabol
oxid
phosphoryl
glycolysi
inflammatori
natur
thu
specul
mainten
adequ
oxpho
metabol
enabl
reduc
inflammatori
respons
stimul
lp
howev
factor
affect
mitochondri
function
well
known
investig
role
regul
inflamm
modul
mitochondri
function
mitogen
activ
protein
kinas
map
kinas
integr
intracellular
signal
pathway
mediat
inflamm
cell
survivaldeath
prolifer
differenti
respons
wide
varieti
signal
cytokin
growth
factor
uv
light
osmot
stress
lipopolysaccharid
lp
map
kinas
kinas
major
upstream
kinas
map
kinas
phosphoryl
respons
lp
map
kinas
ancient
evolutionarili
conserv
compon
metazoan
defens
pathogen
attack
predat
canon
tolllikereceptor
previous
describ
role
sepsi
syndrom
excess
inappropri
inflammatori
respons
infect
also
found
defici
lead
less
lung
inflamm
better
surviv
variou
model
sepsi
cecal
ligat
punctur
clp
lp
exposur
addit
found
defici
endotheli
cell
larger
pool
healthi
mitochondria
shown
higher
mitophagi
clearanc
dysfunct
mitochondria
increas
mitochondri
biogenesi
report
mitochondri
ro
regul
regul
mitochondri
function
report
best
knowledg
thu
hypothes
defici
specif
effect
mitochondria
turn
potent
modul
inflamm
sought
examin
effect
delet
mitochondri
function
cytokin
secret
lp
exposur
bone
marrow
deriv
macrophag
bmdm
provid
good
cell
model
studi
inflammatori
respons
mitochondri
function
show
delet
lead
better
mitochondri
function
lower
product
ro
reduct
activ
activ
lower
cytokin
releas
lp
stimul
thu
conclud
mitochondri
dysfunct
contribut
lpsinduc
inflammatori
respons
bmdm
play
import
role
mice
origin
provid
r
davi
univers
massachusett
medic
school
worcest
r
flavel
yale
univers
new
ct
backcross
onto
background
gener
previous
describ
mice
gener
mice
express
normal
level
jnk
map
kinas
mice
divid
group
ie
wild
type
control
background
wild
type
lp
treat
control
lp
treat
lp
escherichia
coli
sigmaaldrich
given
singl
acut
dose
mgkg
ip
ld
blood
collect
lp
treatment
serum
cytokin
analysi
experi
conduct
accord
nih
guidelin
approv
institut
anim
care
use
committe
bmdm
isol
differenti
use
standard
protocol
primari
macrophag
deriv
bone
marrow
cell
cultur
day
media
contain
cell
condit
medium
fetal
bovin
serum
penicillin
streptomycin
penstrep
cell
condit
medium
prepar
grow
cell
contain
fetal
bovin
serum
penstrep
day
bmdm
harvest
treat
ice
cold
dpb
contain
edta
plate
per
experiment
requir
bmdm
seed
densiti
cell
per
well
plate
expos
lp
estim
mitochondri
membran
potenti
perform
use
enzo
life
scienc
membran
permeabl
fluoresc
probe
enter
select
mitochondria
exist
two
form
monomer
aggreg
depend
upon
monom
form
predomin
mitochondria
low
emit
green
wavelength
nm
aggreg
form
accumul
mitochondria
high
emit
orang
wavelength
nm
aggregatemonom
ratio
proport
mmp
final
concentr
use
media
incub
min
read
fluoresc
spectramax
gemini
xs
spectrofluromet
molecular
devic
total
atp
determin
use
atp
fluorometr
assay
kit
biovis
bmdm
cell
per
well
six
well
cell
cultur
plate
lp
treatment
lyse
atp
assay
buffer
centrifug
supernat
mix
atp
probe
atp
convert
develop
mix
incub
room
temperatur
dark
fluoresc
read
ex
use
spectrofluromet
vmax
molecular
devic
valu
calcul
provid
standard
analyz
seahors
bioscienc
north
billerica
use
measur
bioenerget
function
intact
bmdm
real
time
bmdm
seed
seahors
bioscienc
cell
cultur
plate
seed
densiti
cell
media
allow
adher
grow
humidifi
incub
co
measur
extracellular
flux
made
unbuff
media
extracellular
acidif
rate
ecar
calcul
baselin
compar
rate
glycolysi
mitochondri
function
analys
sequenti
ad
pharmacolog
inhibitor
oxid
phosphoryl
result
bioenerget
profil
provid
detail
inform
individu
compon
mitochondri
bioenerget
compon
cellular
level
ro
mitochondri
superoxid
determin
use
cmh
dcfda
mitosox
respect
bmdm
cultur
plate
densiti
cell
per
well
media
chang
cmh
dcfda
final
concentr
mitosox
final
concentr
ad
along
nuclear
stain
hoechst
min
cell
wash
twice
suspend
dpb
fluoresc
read
ex
hoechst
ex
cmh
dcfda
ex
mitosox
cellular
ro
mitochondri
superoxid
data
normal
nuclear
stain
quantifi
bmdm
seed
cell
per
well
cell
cultur
plate
media
chang
lp
treatment
done
addit
atp
last
min
cell
lyse
cell
lysi
buffer
provid
fluorometr
assay
kit
abcam
activ
determin
use
cell
lysat
protein
manufactur
protocol
assay
base
spectrophotometr
detect
chromophor
pnitroanilid
pna
cleavag
label
substrat
yvadpna
absorb
standard
curv
pna
prepar
data
express
pna
releas
mg
protein
bmdm
cultur
coverslip
cell
cultur
plate
confluenc
cell
treat
lp
cell
wash
dpb
twice
fix
paraformaldehyd
min
fixat
cell
wash
dpb
permeabilis
block
dako
proteinfre
block
buffer
antibodi
cat
cell
signal
tech
inc
ad
block
buffer
incub
overnight
two
dpb
wash
antirabbit
cat
invitrogen
secondari
antibodi
incub
wash
dpb
mount
mount
media
contain
dapi
imag
taken
confoc
microscopi
quantifi
use
cellprofil
softwar
broad
institut
amount
stain
within
nucleu
quantifi
plot
blood
collect
cardiac
punctur
bd
microtain
serum
separ
tube
without
addit
blood
sampl
allow
clot
room
temperatur
minut
centrifug
min
serum
collect
store
analyz
bmdm
media
cell
per
well
well
cell
cultur
plate
collect
lp
treatment
analyz
cytokin
level
use
luminex
fluoresc
bead
base
technolog
biorad
cytokin
standard
run
along
sampl
calcul
amount
pgml
deplet
bmdm
sirna
santa
cruz
cat
use
nonspecif
sirna
scrambl
duplex
probe
sens
antisens
synthes
dharmacon
research
inc
previous
describ
bmdm
confluenc
transfect
sirna
use
miru
reagent
miru
madison
wi
accord
manufactur
manual
experi
perform
fresh
media
chang
bmdm
per
well
six
well
cell
cultur
plate
treat
lp
min
wash
twice
dpb
make
lysat
total
cellular
lysat
prepar
use
ripa
buffer
mm
trishcl
ph
mm
triton
aprotinin
proteas
phosphatas
inhibitor
roch
protein
separ
precast
miniprotean
tgx
gel
biorad
transfer
pvdf
membran
millipor
membran
incub
room
temperatur
nonfat
milk
tri
buffer
salin
tbst
block
incub
primari
antibodi
secondari
antibodi
tag
hrp
use
appropri
primari
antibodi
host
blot
develop
chemiluminesc
substrat
ecl
amersham
primari
antibodi
use
jnk
pjnk
erk
perk
cleav
procur
cell
signal
technolog
inc
danver
hrp
tag
antibodi
santa
cruz
biotech
data
present
mean
sem
statist
analysi
perform
use
ttest
analysi
p
consid
signific
compar
inflammatori
respons
mice
wild
type
mice
mice
treat
lp
blood
collect
analyz
serum
cytokin
level
mice
significantli
lower
serum
level
eotaxin
gmcsf
compar
wild
type
mice
measur
cytokin
significantli
differ
show
similar
trend
differ
baselin
level
cytokin
wild
type
mice
figur
studi
inflammatori
respons
cellular
level
use
bmdm
mice
bmdm
expos
lp
media
collect
measur
cytokin
level
wild
type
bmdm
lp
stimul
lead
increas
secret
cytokin
media
howev
bmdm
mice
show
attenu
inflammatori
respons
lp
exposur
promin
found
vivo
studi
level
eotaxin
gcsf
gmcsf
kc
rant
significantli
lower
bmdm
media
compar
wt
baselin
well
stimul
lp
level
differ
baselin
lp
stimul
bmdm
significantli
lower
level
compar
wt
antiinflammatori
cytokin
level
significantli
higher
bmdm
baselin
also
lp
stimul
compar
wt
figur
result
indic
regul
cytokin
respons
lp
stimulu
understand
role
mitochondri
function
inflammatori
respons
measur
oxygen
consumpt
rate
ocr
wt
bmdm
seahors
bioscienc
extracellular
flux
analyz
observ
higher
ocr
bmdm
compar
wt
figur
analyz
basal
respir
rate
atp
product
significantli
higher
wt
figur
data
show
higher
oxygen
demand
concomitantli
higher
product
atp
extracellular
acidif
rate
ecar
measur
glycolysi
also
higher
bmdm
correl
higher
mitochondri
respir
figur
result
indic
higher
metabol
rate
bmdm
lp
stimul
observ
chang
mitochondri
function
compar
baselin
wt
bmdm
drop
mitochondri
membran
potenti
mmp
wt
bmdm
lp
treatment
bmdm
figur
atp
content
higher
bmdm
compar
wt
chang
lp
treatment
figur
compar
differ
oxid
level
wt
bmdm
measur
ro
lp
exposur
wt
bmdm
show
signific
increas
ro
mitosox
level
even
baselin
bmdm
lower
level
total
cellular
ro
mitosox
figur
nuclear
transloc
critic
event
activ
inflammatori
gene
respons
inflammatori
stimuli
studi
model
system
bmdm
treat
lp
probe
immunocytochemistri
along
nuclear
stain
slide
imag
confoc
microscopi
quantifi
cellprofil
softwar
wt
bmdm
lp
treatment
show
signific
increas
nuclear
signific
increas
bmdm
figur
suggest
attenu
inflammatori
respons
bmdm
lp
stimul
least
partli
due
lower
activationnuclear
transloc
key
compon
inflammasom
drive
matur
cytokin
extracellular
secret
find
signific
activ
lp
treatment
wt
bmdm
atp
ad
last
min
lp
treatment
observ
signific
increas
activ
wt
bmdm
figur
furthermor
bmdm
lpsatp
treatment
group
significantli
lower
cleav
wt
shown
western
blot
figur
data
indic
also
influenc
activ
either
directli
indirectli
inflammatori
condit
studi
effect
lpsinduc
downstream
signal
event
studi
mapk
mitogen
activ
protein
kinas
famili
mapk
famili
consist
extracellular
signalregul
kinas
jnk
jun
ntermin
kinas
lp
stimul
bmdm
lower
induct
pjnk
compar
wt
differ
perk
respons
wt
bmdm
figur
result
indic
affect
activ
jnk
turn
affect
phosphoryl
confirm
find
treat
wt
bmdm
sirna
check
mitochondri
function
inflammatori
respons
sirna
treatment
caus
decreas
level
measur
pcr
wherea
chang
nonspecif
sirna
ns
sirna
treat
bmdm
data
shown
mmp
higher
sirnatr
bmdm
compar
ns
sirnatr
bmdm
figur
nuclear
transloc
well
activ
respons
lp
lower
sirna
bmdm
compar
ns
sirnatr
bmdm
figur
c
baselin
level
gcsf
kc
rant
lower
sirnatr
bmdm
lp
exposur
result
increas
cytokin
chemokin
measur
respons
significantli
attenu
sirnatr
bmdm
figur
result
clearli
implic
inflammatori
respons
bmdm
lp
stimul
sepsi
acut
system
inflammatori
condit
lifethreaten
condit
lead
death
us
make
lead
caus
mortal
icu
patient
hallmark
sepsi
dysregul
overwhelm
inflammatori
respons
character
massiv
cytokin
releas
oxid
stress
mitochondri
dysfunct
sever
line
evid
genet
function
suggest
mitochondri
function
primari
target
acut
inflamm
central
determin
clinic
outcom
propos
inflammatori
signal
lead
phosphoryl
cytochrom
oxidas
cox
mitochondri
target
follow
suppress
mitochondri
function
reduc
mitochondri
membran
potenti
mmp
energi
failur
shown
anim
model
sever
inflamm
atp
level
significantli
reduc
compar
control
similar
result
report
septic
patient
reduc
atp
level
found
nonsurvivor
group
compar
survivor
group
addit
organ
failur
sepsi
link
atp
deplet
lp
induc
lung
injuri
associ
reduc
atp
recent
publish
studi
gene
express
profil
identifi
gene
associ
sepsi
human
patient
found
compon
mitochondri
respiratori
complex
atp
synthas
regul
septic
patient
concomit
increas
compon
chemokin
signal
pathway
ie
forkhead
box
signal
transduc
activ
transcript
murin
leukemia
viral
oncogen
homolog
context
earlier
shown
mice
resist
septic
injuri
moreov
cell
tissu
show
higher
mitochondri
biogenesi
mitophagi
lead
larger
pool
healthi
mitochondria
studi
show
neg
affect
mitochondri
function
could
driver
inflammatori
outcom
septic
condit
bmdm
show
higher
oxygen
consumpt
baselin
also
higher
atp
product
mmp
atp
level
higher
bmdm
indic
better
mitochondri
function
could
import
reason
attenu
cytokin
respons
lpsinduc
inflamm
ro
contribut
inflammatori
respons
activ
key
signal
pathway
includ
redox
sensit
transcript
factor
pathway
nuclear
factor
inflammasom
mitochondria
produc
bodi
energi
need
form
atp
via
oxid
phosphoryl
major
ro
product
occur
within
mitochondria
atp
gener
also
major
sourc
intracellular
ro
mitochondria
major
target
rosmedi
damag
mitochondri
ro
mtro
import
cellular
signal
also
caus
cell
damag
tightli
regul
endogen
antioxid
scaveng
system
limit
damag
condit
stress
diseas
ro
product
increas
antioxid
protect
decreas
mitochondri
damag
occur
inflamm
increas
creat
viciou
cycl
selfsustain
amplifi
cycl
ro
gener
inflammatori
respons
mitochondri
impair
contribut
organ
failur
patient
sepsi
bmdm
show
lower
level
ro
mitosox
baselin
well
lp
treatment
could
due
either
better
ro
scaveng
mechan
higher
effici
respiratori
complex
lead
reduc
ro
product
although
ro
clearli
part
septic
sequenc
specif
role
import
rel
energi
crisi
compon
examin
base
data
appar
dual
effect
mitochondri
function
ro
gener
well
activ
map
kinas
jnk
affect
inflammatori
outcom
studi
show
defici
significantli
reduc
inflammatori
respons
regul
two
major
inflammatori
pathway
ie
inflammasom
inflammatori
respons
stimuli
seen
twostep
process
first
pathogen
associ
molecular
pattern
pamp
includ
lp
prototyp
pamp
induc
transcript
respons
product
cytokin
mrna
protein
mediat
transcript
factor
step
inflammasom
activ
mediat
damag
associ
molecular
pattern
damp
help
secret
matur
cytokin
mitochondria
central
inflammatori
respons
affect
step
known
inflammatori
transcript
factor
redox
sensit
activ
mitochondri
ro
observ
reduc
activ
lp
exposur
bmdm
could
due
insuffici
increas
ro
damag
mitochondria
releas
damp
oxid
mitochondri
dna
cytoplasm
rev
inflammatori
respons
activ
inflammasom
inflammasom
multiprotein
complex
promot
cleavag
mani
procytokin
biolog
activ
form
addit
activ
cleav
substrat
like
sterol
regulatori
elementbind
protein
srebp
therefor
play
import
role
cell
death
surviv
data
suggest
improv
mitochondri
function
bmdm
prevent
activ
instrument
inflammatori
cytokin
releas
lp
exposur
report
support
argument
shown
presenc
activ
mitochondri
ro
oxid
mtdna
import
player
activ
inflammasom
given
import
role
mitochondria
gener
inflamm
modul
mitochondri
function
could
potenti
antiinflammatori
agent
sever
mitochondriatarget
therapi
test
includ
treatment
mitochondri
substrat
eg
carnitin
succin
mgcl
atp
cofactor
eg
coenzym
q
acid
antioxid
ro
scaveng
eg
mitoq
skq
phenyltertbutylnitron
nacetylcystein
tempol
membran
stabil
eg
cyclosporin
melatonin
restor
mitochondri
function
extent
howev
interf
inflammatori
signal
along
mitochondri
function
might
result
better
outcom
exampl
synthet
cortisol
homologu
dexamethason
affect
sever
signal
pathway
includ
mapkerk
signal
shown
partial
rescu
cox
function
h
cecal
ligat
punctur
cortex
outer
stripe
outer
medulla
mous
kidney
base
result
appar
potenti
target
reduc
inflamm
septic
condit
kinas
well
known
druggabl
target
mani
kinas
inhibitor
current
develop
mitogen
activ
protein
kinas
map
kinas
mapk
focu
intens
ultim
unsuccess
search
inhibitor
antiinflammatori
antisepsi
applic
limit
factor
inhibitor
signific
side
effect
restrict
clinic
use
inhibit
show
side
effect
associ
inhibit
downstream
signal
tune
differ
two
kinas
conclus
demonstr
mediat
lp
induc
inflammatori
respons
improv
mitochondri
function
thu
repres
attract
therapeut
target
treatment
sepsi
lp
intra
periton
inject
mice
serum
collect
analyz
level
cytokin
mice
show
attenu
inflammatori
respons
compar
wild
type
mice
lp
injuri
baselin
cytokin
level
mice
differ
wt
mice
repres
signific
control
lp
treat
within
genotyp
repres
signific
genotyp
control
lp
treatment
group
repres
signific
p
repres
signific
p
measur
done
serum
mice
per
group
bmdm
cell
media
collect
lp
treatment
cytokin
level
measur
bmdm
show
lesser
cytokin
releas
lp
treatment
also
baselin
repres
signific
control
lp
treat
within
genotyp
repres
signific
genotyp
control
lp
treatment
group
repres
signific
p
repres
signific
p
data
repres
independ
experi
done
triplic
bmdm
treat
lp
atp
check
activ
activ
significantli
increas
wt
lp
atp
treatment
bmdm
show
signific
chang
compar
control
level
cleav
lower
bmdm
compar
wt
lp
atp
treatment
b
repres
signific
control
lp
treat
within
genotyp
repres
signific
genotyp
within
lp
treatment
group
repres
signific
p
data
repres
experi
done
least
triplic
wt
bmdm
transfect
sirna
show
higher
mmp
compar
control
ie
nonspecif
sirna
ns
sirna
transfect
nuclear
transloc
lower
sirna
transfect
bmdm
compar
control
lp
treatment
b
activ
lower
sirna
transfect
bmdm
lp
atp
injuri
compar
control
c
cytokin
releas
lower
lp
expos
sirna
treat
bmdm
compar
ns
sirna
treamtment
mmp
graph
repres
signific
p
activ
graph
repres
signific
among
treatment
within
genotyp
p
cytokin
graph
repres
signific
control
lp
treat
within
sirna
treatment
repres
signific
differ
sirna
treatment
control
lp
treatment
group
repres
signific
p
repres
signific
p
data
repres
experi
done
least
triplic
